Investigation Into the Correlation of Plasma Hs-CRP Concentrations and Cardiovascular Risk in Korean Population (CALLISTO)

AstraZeneca

Status: Completed

Conditions: hsCRP

Study type: Observational

Funder types: Industry

Identifiers

NCT00819273

NIS-CKR-DUM-2008/5

Details and patient eligibility

About

An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.

Enrollment: 1,700 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects with at least one clinic visit record within the last 12 months from the date of data entry.
• Subjects with at least one hs-CRP level measured within the last 12 months from the date of data entry.

Exclusion criteria

• Use of statins or other lipid-lowering therapies including fibrates, niacin, and bile acid sequestrants in the past 3 months prior to hsCRP measurement
• Active inflammatory diseases documented during the period of CRP measurement
• Subjects taking immunosuppressants
• Findings of chronic inflammation: arthritis, lupus, or inflammatory bowel disease

Trial design

1,700 participants in 1 patient group

1

Description:

patients who have records of clinic visit with circulatory and endocrine internal medicines of nationwide tertiary hospitals within the last one year.